An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
Public ClinicalTrials.gov record NCT02856802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of DFN-02 in Episodic Migraine With or Without Aura
Study identification
- NCT ID
- NCT02856802
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Upsher-Smith Laboratories
- Industry
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- Sumatriptan 10 mg Nasal Spray Drug
- Sumatriptan Placebo Nasal Spray Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 10, 2016
- Primary completion
- Feb 9, 2017
- Completion
- Feb 9, 2017
- Last update posted
- Mar 29, 2021
2016 – 2017
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 30 | San Diego | California | 92108 | — |
| Site 11 | Santa Monica | California | 90404 | — |
| Site 31 | Boston | Massachusetts | 02131 | — |
| Site 18 | Ann Arbor | Michigan | 48104 | — |
| Site 02 | Albuquerque | New Mexico | 87102 | — |
| Site 29 | Rochester | New York | 14609 | — |
| Site 25 | Williamsville | New York | 14221 | — |
| Site 33 | Mt. Pleasant | South Carolina | 29464 | — |
| Site 28 | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02856802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2021 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02856802 live on ClinicalTrials.gov.